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A B S T R A C T
Nonalcoholic fatty liver disease (NAFLD) is associated with dietary folate deficiency and mutations in genes
required for one‑carbon metabolism. However, the mechanism through which this occurs is unclear. To improve
our understanding of this link, we investigated liver morphology, metabolism and fuel storage in adult mice with
a hypomorphic mutation in the gene methionine synthase reductase (Mtrrgt). MTRR enzyme is a key regulator of
the methionine and folate cycles. The Mtrrgt mutation in mice was previously shown to disrupt one‑carbon
metabolism and cause a wide-spectrum of developmental phenotypes and late adult-onset macrocytic anaemia.
Here, we showed that livers of Mtrrgt/gt female mice were enlarged compared to control C57Bl/6J livers.
Histological analysis of these livers revealed eosinophilic hepatocytes with decreased glycogen content, which
was associated with down-regulation of genes involved in glycogen synthesis (e.g., Ugp2 and Gsk3a genes).
While female Mtrrgt/gt livers showed evidence of reduced β-oxidation of fatty acids, there were no other asso-
ciated changes in the lipidome in female or male Mtrrgt/gt livers compared with controls. Defects in glycogen
storage and lipid metabolism often associate with disruption of mitochondrial electron transfer system activity.
However, defects in mitochondrial function were not detected inMtrrgt/gt livers as determined by high-resolution
respirometry analysis. Overall, we demonstrated that adult Mtrrgt/gt female mice showed abnormal liver mor-
phology that differed from the NAFLD phenotype and that was accompanied by subtle changes in their hepatic
metabolism and fuel storage.
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A connection between one‑carbon metabolism and fatty liver dis-
ease (steatosis) is well established [1]. This is largely based on studies
showing that humans and rodents fed diets deficient for one‑carbon
methyl groups (e.g., choline, folate, methionine, betaine) and/or have
specific mutations in genes involved in one‑carbon metabolism (e.g.,
Mat1a, Pemt, Gnmt, Mthfr) develop fatty livers [2–7]. Furthermore,
patients with liver disease often have abnormal expression of key genes
involved in methionine metabolism and hyperhomocysteinemia [8].
However, the mechanism through which this occurs is not well un-
derstood.
One‑carbon metabolism is at a major junction of several metabolic
processes [9]. For instance, it has been implicated in hepatic lipid
[10,11] and glycogen metabolism [5,12]. In liver, methyl groups from
SAM are required for the sequential methylation of phosphatidyletha-
nolamine (PE) to form phosphatidylcholine (PC) [13,14], the most
abundant membrane phospholipid [15,16]. Liver cells have a high de-
mand for PC synthesis, such that it requires as much as 40% of S-ade-
nosylmethionine (SAM) for this purpose [17]. Disruption of hepatic PC
production leads to steatosis in mice through accumulation of tria-
cylglycerols (TAGs) and impaired secretion of very low-density lipo-
protein particles [18,19]. Apart from hepatic lipid accumulation, gly-
cogen storage disease is also associated with hyperhomocysteinemia
[12] caused by perturbation of one‑carbon metabolism. Furthermore,
mice that lack the enzyme glycine N-methyltransferase (GNMT), which
regulates the ratio of SAM to S-adenosylhomocysteine (SAH) [20], de-
velop glycogen storage disease in the liver [5]. Better understanding of
how one‑carbon metabolism is connected to lipid and glycogen meta-
bolism in the liver will help us gain insight into disease.
During one‑carbon metabolism, the enzyme methionine synthase
(MTR, also known as MS), which contains a cobalamin (vitamin B12)
cofactor, catalyzes the transfer of methyl groups from 5-methylte-
trahydrofolate (5-methyl-THF) to cob(I)alamin to produce methylco-
balamin. It donates this methyl group to methylate homocysteine to
form methionine [21,22]. Methionine acts as a precursor for SAM,
which then serves as a methyl donor for dozens of substrates including
DNA, RNA, proteins (e.g., histones) and lipids (e.g., PE) [13,14,23–25].
In mammals, the cob(I)alamin cofactor of MTR becomes oxidized by
molecular oxygen forming the inactive cob(II)alamin form. Methionine
synthase reductase (MTRR or MSR) provides the electron that, along
with the transfer of a methyl group from SAM, returns MTR to the
active methylcobalamin form [26]. MTR is the only mammalian en-
zyme that uses 5-methyl-THF and deficiencies in MTR or MTRR causes
an accumulation 5-methyl-THF that makes folate unavailable for other
reactions, such as purine and pyrimindine biosynthesis [8,21]. There-
fore, MTR and MTRR are key enzymes required for the progression of
one‑carbon metabolism.
Mutations in humanMTR andMTRR genes have not previously been
associated with hepatosteatosis or glycogen storage disease. Mouse
knockout mutations in Mtr and Mtrr, and other genes important for
folate uptake and transport, are not conducive with life [21,27–29],
resulting in embryonic lethality that prevents the assessment of liver
disease in adulthood. We have developed a mouse model with a hy-
pomorphic mutation in the Mtrr gene (Mtrrgt) that displays many key
features of dietary folate deficiency or MTRR mutations in humans
[30–34]. These include increased plasma total homocysteine con-
centrations [21,35], decreased plasma methionine concentrations [21],
an altered hepatic SAM:SAH ratio [21], and tissue-specific dysregula-
tion of DNA methylation [35]. These phenotypes are attributed to a
substantial decrease in MTR activity [21]. We previously showed that
Mtrrgt/gt mice exhibit a wide spectrum and frequency of phenotypes
during fetoplacental development (e.g. neural tube and heart defects,
growth phenotypes), a portion of which are associated with embryonic
lethality at midgestation [35]. The Mtrrgt/gt mice that survive into
adulthood display late onset macrocytic anaemia [36]. However, it is
unknown whether adult livers of Mtrrgt/gt mice display liver disease
similar to other mouse models of defective one‑carbon metabolism.
Here, we explored the effects of Mtrrgt/gt homozygosity on glycogen and
lipid storage and metabolism in adult livers. In doing so, we also in-
vestigated whether there were associated alterations in mitochondrial
function that often accompany NAFLD and glycogen storage disease
[37–40].
2. Materials and methods
2.1. Mice and genotyping
All animal work was carried out in accordance with UK Home Office
regulations under the Animals (Scientific Procedures) Act 1986 and
underwent review by the University of Cambridge Animal Welfare and
Ethical Review Body. The Mtrrgt mouse line was generated through a
gene-trap (gt) insertion into the Mtrr locus and upon germline trans-
mission, the Mtrrgt mutation was backcrossed to the C57Bl/6J genetic
background for eight generations as previously described in detail
[21,35]. C57Bl/6J mice (The Jackson Laboratory, Bar Harbour, ME,
USA), which are wildtype for Mtrr, were used as controls for all ex-
periments, and were maintained in house and bred separately from the
Mtrrgt mouse line. Mtrrgt/gt mice were generated via Mtrrgt/gt inter-
crosses. From birth, mice were housed in conventional cages in a
temperature and humidity-controlled environment with a 12 h light/
dark cycle. Mice were fed normal breeding diet (Rodent No. 3 breeding
chow, Special Diet Services, Essex, UK) ad libtum from weaning on-
wards. A full dietary breakdown of the chow was previously described
[35] including folic acid at 2.99 mg/kg of diet, methionine at 0.37%,
choline at 1422.4 mg/kg of diet, and vitamin B12 at 19.2 μg/kg of diet.
All female mice were virgins. DNA samples were obtained from ear
tissue for PCR genotyping of the Mtrrgt allele as reported earlier [35].
2.2. Tissue collection
Mice were euthanized by cervical dislocation at 9–16 weeks of age.
Prior to dissection, mouse body weight was recorded. Whole livers were
removed and weighed. The left lobe of each liver was dissected im-
mediately in cold 1× phosphate buffered saline (1× PBS) diluted in
diethyl-pyrocarbonate treated water and placed into ice-cold biopsy
preservation medium (2.77 mM CaK2EGTA, 7.23 mM K2EGTA,
6.56 mMMgCl2.6H2O, 20 mM taurine, 15 mM phosphocreatine, 20 mM
imidazole, 0.5 mM dithiothreitol, 50 mM MES, 5.77 mM Na2ATP,
pH 7.1) for respirometry analysis. The right lateral lobe was prepared
for histological analysis. The remaining liver tissue was snap-frozen in
liquid nitrogen and stored at −80 °C for molecular analysis.
2.3. RNA extraction and quantitive reverse transcription PCR (RT-qPCR)
For analysis of folate metabolism and mitochondrial genes, tissue
was homogenized using Lysing Matrix D beads (MP Biomedicals,
Eschwege, Germany). Total RNA extraction from livers was completed
using Trizol (Sigma-Aldrich) according to the manufacturer's instruc-
tions. All extracts were treated with DNase I (Thermo Fisher Scientific,
Hemel Hempstead, UK). Reverse-transcription was performed with a
RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific)
using 2 μg RNA in a 20-μl reaction. PCR amplification was conducted
using MESA SYBR® Green qPCR MasterMix Plus (Eurogentec, Liege,
Belgium) on a DNA Engine Opticon® 2 system (BioRad, Hercules, CA,
USA). Transcript levels were normalized to Hprt or Bactin RNA levels.
Fold change was quantified using the standard curve method. cDNA
levels in C57Bl/6 J tissue were normalized to 1. Experiments were
conducted in triplicate with at least three biological replicates.
For analysis of glycogen metabolism genes, RNA was extracted
using the GenElute Mammalian Total RNA Miniprep Kit (Sigma-
Aldrich) including OnColumn DNase treatment (Sigma-Aldrich).
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Reverse transcription was performed using SuperScript IV Reverse
Transcriptase (Thermo Scientific) and Random Hexamers (Thermo
Scientific) according to manufacturer's instructions using 1 μg total
RNA as template. PCR amplification was performed using 2 μl of cDNA
(diluted 1:10 in water) in a 10-μl reaction containing 1× DreamTaq
Buffer (Thermo Scientific), 0.2 mM of each dNTP (Thermo Scientific),
0.5 μM of each primer (Sigma-Aldrich), 0.5 U DreamTaq (Thermo
Scientific) and 0.1× SYBR® Green Dye (Thermo Scientific). Reactions
were run in triplicate on a DNA Engine Opticon® 2 system (BioRad).
Transcript levels were normalized to the geometric mean of Hprt and
Bactin levels and fold change determined using the 2-ΔΔCT method with
expression levels in C57Bl/6 J tissue normalized to 1.
Refer to Supplementary table 1 for primer sequences.
2.4. Tissue preparation and histological stains
Livers were fixed in 4% paraformaldehyde (PFA) in 1× PBS, em-
bedded in paraffin using standard techniques and sectioned to 7 μm
using a Leica RM2235 microtome (Leica Biosystems, Milton Keynes,
UK). For each staining protocol, at least six histological sections from
different regions of each liver (N = 3 female mice per genotype) were
analysed. Tissue sections were stained with hematoxylin and eosin (H&
E) or using a periodic acid-Schiff stain kit (Sigma-Aldrich, Gillingham,
UK) according to standard protocols or the manufacturer's instructions.
For immunohistochemistry, tissue sections were incubated in 3% H2O2
in 1× PBS for 30 min, treated with porcine trypsin tablets (Sigma-
Aldrich) for 10 min, then incubated with blocking serum (5% donkey
serum, 1% bovine serum albumin in 1× PBS) for 1 h. Tissue was then
incubated in rabbit anti-mouse Ki67 IgG (abcam, Cambridge, UK, cat.
No. ab15580, RRID:AB_443209) diluted to 1:100 in blocking serum
overnight at 4 °C, then in donkey anti-rabbit IgG conjugated to horse-
radish peroxidase (abcam cat No. ab6802, RRID:AB_955445) diluted to
1:300 in blocking serum for 1 h at room temperature. Peroxidase sub-
strate reactions were conducted with 3,3′-diaminobenzidine (DAB)
chromagen substrate kit (abcam) according to the manufacturer's in-
structions. Sections were counterstained in Nuclear Fast Red (Sigma-
Aldrich) before dehydration, clearing and coverslip mounting in DPX
mountant (Sigma-Aldrich).
2.5. High-resolution respirometry analysis of mitochondrial function
From each left lobe of liver, 15–20 mg sections were cut, blotted dry
and quickly weighed before immediate homogenisation in ice-cold re-
spiratory medium (MiR05; 0.5 mM EGTA, 3 mM MgCl2.6H2O,
60 mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES,
110 mM sucrose, 1 mg.ml−1 defatted bovine serum albumin, pH 7.1) at
a final concentration of 100 μg.μl−1. Homogenisation was carried out
using an Eppendorf pestle and a DLH overhead stirrer (Velp Scientifica,
Usmate, Italy) with a maximum of five pulses of no longer than 5 s at
600 rpm until a consistent homogenate was generated. Liver homo-
genate (20 μl, equivalent to 2 mg wet tissue) was added to each
chamber of an Oxygraph-2 k (Oroboros Instruments, Innsbruck,
Austria) containing 2.1 ml MiR05 at 37 °C with continuous stirring.
Oxygen flux (JO2) was continuously recorded using DatLab software 6.1
(Oroboros Instruments). Calibration at air saturation was carried out
every day prior to experimentation and all data was corrected for
background instrumental oxygen flux in accordance with the manu-
facturer instructions.
Respiration rates were analysed using a substrate-uncoupler titra-
tion that was run in duplicate on each biological replicate. JO2 through
the N-pathway via electron transfer system (ETS) complex I was as-
sayed in the LEAK state through addition of 1 mM malate and 10 mM
glutamate (GML). Subsequently, N-pathway supported oxidative phos-
phorylation (OXPHOS state) was stimulated through addition of 10 mM
ADP (GMP). Maximal OXPHOS capacity was then assessed via addition
of 10 mM succinate (GMSP), which can supply electrons through the S-
pathway via complex II. Finally, the ETS was uncoupled from F1FO-ATP
synthase through addition of the protonophore carbonyl cyanide p-tri-
fluoro-methoxyphenyl hydrazone (FCCP) in 0.5 μM increments until
maximal ETS capacity was observed (GMSE). Respiration rates were
normalized to wet tissue mass and also to maximal ETS capacity
(GMSE).
2.6. Citrate synthase and 3-hydroxyacyl-CoA dehydrogenase (HOAD)
enzyme activity assays
Activities of citrate synthase (EC 2.3.3.1) and HOAD (EC 1.1.1.35)
were analysed spectrophotometrically at 37 °C (Evolution 220
UV–Visible spectrophotometer, Thermo Fisher Scientific). Liver homo-
genate was generated from a small section of frozen tissue in 300 μl
homogenisation buffer (20 mM HEPES, 1 mM EDTA, 0.1% v/v Triton X-
100, pH 7.2) using a liquid nitrogen-cooled Eppendorf pestle. The su-
pernatant was extracted following centrifugation (two spins at 380 xg
for 30 s) and protein density quantified in each sample using a Pierce
BCA Protein Assay Kit (Thermo Fisher Scientific) as per the manu-
facturer instructions. For citrate synthase activity, a sample containing
10 μg of protein was measured as previously described [41]. The citrate
synthase assay buffer contained 18 mM tris-base, 0.1 mM 5,5′-dithiobis
(2-nitrobenzoic acid) and 0.3 mM acetyl-CoA, pH 8.0 and the reaction
stimulated by addition of 0.5 mM oxaloacetate. The change in absor-
bance was measured at 412 nm to determine citrate synthase activity.
For HOAD activity, a sample containing of 20 μg protein was measured
as previously described [42]. The HOAD assay buffer contained 50 mM
imidazole, 0.1% v/v Triton X-100 and 0.15 mM NADH at pH 7.4. The
reaction was initiated by addition of 0.1 mM acetoacetyl-CoA and ab-
sorbance change at 340 nm was measured. HOAD activity was cor-
rected to citrate synthase activity to provide an indication of HOAD
activity per mitochondrial unit.
2.7. Lipidomic and acyl-carnitine analysis by liquid chromatography-mass
spectrometry (LC-MS)
Lipid metabolites were extracted from ~50 mg of frozen liver tissue
using a modified Bligh and Dyer method [43]. Each sample was
homogenized in 600 μl of 2:1 methanol/chloroform for 6 min at 20 Hz,
and sonicated for 15 min. To each sample, 400 μl of water/chloroform
(1:1) was added and samples were thoroughly vortexed before cen-
trifugation (13,000 xg, 10 min). The aqueous and organic fractions were
separated. To maximize metabolite yield, the extraction was repeated
on the resultant protein pellet and the aqueous and organic fractions
were separately pooled. Half of the resultant aqueous and organic
fractions were combined for acyl-carnitine analysis and dried under
nitrogen. To the remaining organic fraction, 250 μl of an internal
standard mix containing 16 deuterated lipid standards was added be-
fore drying under nitrogen (see Supplementary table 2) for lipidomics.
For lipidomics, organic metabolites were reconstituted in 100 μl of
methanol/chloroform (1:1) and 10 μl of this solution was diluted to
1:20 in propan-2-ol/acetonitrile/water (2:1:1). Open-profiling of lipid
species was carried out using an Ultimate 3000 UHPLC system (Thermo
Fisher Scientific) coupled to an LTQ Orbitrap Elite Mass Spectrometer
(Thermo Fisher Scientific). Mass spectrometry was performed in both
positive and negative modes. 5 μl of each sample was injected onto a
C18 CSH column (2.1 × 100 mm, 1.7 μM pore size; Waters Ltd., Elstree,
UK), which was held at 55 °C. The flow rate of the mobile phase gra-
dient was 0.4 μl.min−1 with mobile phase A acetonitrile/water solution
(3:2) and mobile phase B acetonitrile/propan-2-ol solution (1:9). The
total run time was 20 min during which the mobile phases ran through
the column in a gradient as follows: 40% B raised to 43% B at 2 min,
50% B at 2.1 min, 54% B at 12 min, 70% B at 12.1 min, 99% B at
18 min, and then 40% B for 2 min.10 mM ammonium formate (Fisher
Scientific) was added to mobile phases A and B for positive mode, and
10 mM ammonium acetate (Sigma Aldrich) added for negative mode.
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Metabolites were ionised by heated electrospray for entry into the mass
spectrometer with a source temperature of 420 °C and capillary tem-
perature of 380 °C. Ionization voltages were set to 3.5 kV in positive
mode and 2.5 kV in negative mode. Data was collected using the
Fourier transform mass spectrometer analyser and the full scan was
performed across an m/z range of 110–2000. Peaks were annotated by
accurate mass using an automated in-house R script and comparison to
the LipidMaps database [44]. Where isobaric species of different classes
were annotated, lipid identity was determined through manual identi-
fication of fragmentation patterns according to published methods
[45–47].
The combined carnitine extraction fraction was reconstituted in
150 μl of a methanol/water (4:1) solution containing an internal stan-
dard mix of eight deuterated acyl carnitines at a concentration of 2 μM
(see Supplementary table 2). The metabolite levels were quantified
using a Vanquish UHPLC+ series (Thermo Fisher Scientific) fitted with
an ACE Excel-2 C18-PFP 5 μm column (100 Å, 150 × 2.1 mm;
Advanced Chromatography Technologies Ltd.) conditioned at 40 °C,
coupled to a TSQ Quantiva Triple Quadripole Mass Spectrometer
(Thermo Fisher Scientific). The mobile phase was pumped at
0.45 ml.min−1 with mobile phase A 0.1% aqueous formic acid solution
and mobile phase B 0.1% formic acid/methanol solution. Mobile phase
B was initially held at 0.5% for 1 min and was then subjected to a linear
increase to 100% B over 9 min, held for 2 min, and then brought back to
initial conditions over 0.1 min. UPLC-MS data acquisition and proces-
sing was carried out using Xcalibur software (version 2.2, Thermo
Fisher Scientific) with putative recognition of the detected metabolites
performed using a targeted MS/MS analysis.
The protein pellet remaining from the metabolite extraction was
homogenized in 250 μl of RIPA buffer and used to spectro-
photometrically quantify the protein concentration using a Pierce BCA
protein assay kit (Sigma-Aldrich) as per the manufacturer's instructions.
All metabolite levels were then normalized to the intensity of an ap-
propriate internal standard and to the protein concentration of the
Fig. 1. Mtrrgt/gt female mouse livers are large with increased
eosinophilia in hepatocytes.
(A) Relative mRNA expression of genes encoding for folate
metabolism enzymes in C57Bl/6J control and Mtrrgt/gt livers
of female mice as determined by RT-qPCR analysis. N = 3–5
females per genotype. MtrrWT, wildtype Mtrr transcript; Mtrr
total, wildtype Mtrr transcript plus gene-trapped Mtrr tran-
script. Data is presented as fold change relative to C57Bl/6J
controls (normalized to 1; mean ± sd). Independent t-tests,
*p < .05, **p < .01. (B) Body mass and (C) liver mass in
C57Bl/6J control and Mtrrgt/gt male (m) and female (f) mice.
(D) Liver mass as a percentage of body mass in male (m) and
female (f) C57Bl/6 J and Mtrrgt/gt mice. N= 4–8 mice per sex
per genotype. Histological sections of C57Bl/6J and Mtrrgt/gt
female livers stained with (E-F) hematoxylin (blue) and eosin
(pink; H&E) or (G-H) an antibody against Ki67 protein
(brown; nuclei counterstained with hematoxylin [blue]).
White arrowhead indicates a strongly eosinophilic hepato-
cyte. Black arrowheads indicate Ki67+ cells. Black boxes in-
dicate regions shown in higher magnification to right. Scale
bars: low magnification, 100 μm; high magnification, (E-F)
25 μm and (G-H) 12.5 μm. (I) Nuclear density in histological
sections of female C57Bl/6J and Mtrrgt/gt livers as represented
the number of cells per mm2. (J) Mitotic cell counts in his-
tological sections of livers from C57Bl/6J and Mtrrgt/gt female
mice as determined by the percentage of hepatocytes that
were Ki67+. At least four liver regions were assessed per fe-
male. N = 3 females per genotype. Independent t-test,
§p = .0592, **p < .01. (K) Relative mRNA expression in
C57Bl/6J control andMtrrgt/gt female livers of Ddit3,Myc, and
Cebpa genes as determined by RT-qPCR analysis. N = 3–5
females per genotype. Data is presented as fold change re-
lative to C57Bl/6J controls (normalized to 1; mean ± sd).
Independent t-tests, *p < .05. Legend: Squares, males;
Circles, females; black, C57Bl/6J; white, Mtrrgt/gt.
A.P. Sowton, et al. Molecular Genetics and Metabolism Reports 23 (2020) 100580
4
sample to account for differences in initial sample size.
2.8. Hepatic glycogen concentration
Glycogen extraction from livers was carried out as previously de-
scribed [48]. Glycogen was extracted from ~100 mg of liver from each
sample and resuspended in 1 ml of H2O. Glycogen content was mea-
sured with a spectrophotometer (490 nm absorbance; Elx800 micro-
plate reader, BioTek, Winooski, VT, USA) using the phenol-sulphuric
acid method [4]. A standard curve was plotted to calculate glycogen
concentrations using serial dilution of rabbit liver glycogen (Sigma-
Aldrich). Glycogen content was measured in duplicate with 6–8 biolo-
gical replicates per genotype and sex.
2.9. Statistics, equipment and software
Statistical analyses were performed using GraphPad Prism 6 soft-
ware (La Jolla, CA, USA). Differences attributable to genotype, sex, or
the interaction of these two factors were assessed through a two-way
analysis of variance (ANOVA) whilst differences between C57Bl/6 J
and Mtrrgt/gt mice within one sex were separately analysed either
through a two-tailed, unpaired Mann-Whitney test or a two-tailed,
unpaired student's t-test. P < .05 was considered significant. A
NanoZoomer 2.0-RS (Hamamatsu) and NDP.view2 viewing software
program (Hamamatsu) were used to obtain images. Histological mea-
surements including Ki67+ and PAS+ cell counts and percentage area
of PAS stain were performed using ImageJ software (NIH, Bethesda,
MD, USA). All graphs were produced using GraphPad Prism 6 software.
PCR primers were designed using Primer-BLAST software [49].
3. Results
3.1. Misexpression of genes that encode for folate metabolic enzymes in
Mtrrgt/gt female liver
The Mtrrgt allele is a knock-down mutation that leads to the dis-
ruption of one‑carbon metabolism in liver including a 62% reduction in
MTR activity associated with plasma hyperhomocysteinemia and tissue-
specific alterations in DNA methylation [21,35]. Using RT-qPCR, we
confirmed that the wildtypeMtrr transcript was significantly reduced in
Mtrrgt/gt female liver to 24.1 ± 10.0% (mean ± sd) of C57Bl/6J
control transcript levels (p = .0016; Fig. 1A). This result was in line
with a previous report, which also showed a corresponding reduction in
wildtype MTRR protein expression in Mtrrgt/gt livers [21]. Of note,
Mtrrgt/gt female livers displayed elevated expression of total Mtrr tran-
scripts (including wildtype and gene-trapped Mtrr transcripts) relative
to controls (150.4 ± 37.3% of C57Bl/6J transcripts, p = .033;
Fig. 1A), which was different to a previous study [21] and suggested a
potential transcriptional regulatory feedback loop. Differences in total
Mtrr RNA expression levels in Mtrrgt/gt livers between studies might be
due to the controls used: C57Bl/6J livers [this study] versus Mtrr+/+
littermates [21]. Similarly, other genes that encode for folate metabo-
lism enzymes in Mtrrgt/gt female livers were also up-regulated, such as
Mthfr and Mtr (132.7 ± 21.0% [p = .033] and 139.9 ± 19.5%
[p= .024] of C57Bl/6J transcripts, respectively; Fig. 1A). However, the
expression of Bhmt and Bhmt2 genes, which provide an alternate
pathway for methylation of homocysteine [50], was unchanged in
Mtrrgt/gt female livers compared to controls (Fig. 1A). Altogether, these
data suggest possible transcriptional compensation for Mtrr knock-
down via the selective up-regulation of other genes involved in
one‑carbon metabolism. Whether these transcriptional changes lead to
alterations in protein level or function requires confirmation.
3.2. Hepatocytes are eosinophilic in Mtrrgt/gt female mice
To explore the effects of theMtrrgt mutation on body mass, male and
female Mtrrgt/gt mice were weighed and compared to C57Bl/6J controls
(N = 4–8 mice per group). Mtrrgt/gt homozygosity resulted in low body
weight in male and female mice relative to controls (p < .05, Fig. 1B).
Next, liver mass was assessed. While Mtrrgt/gt males showed a propor-
tional decrease in liver and body mass (p= .343), Mtrrgt/gt female livers
represented a greater percentage of body mass than controls
(p = .0006; Fig. 1C-D). This result indicated that the Mtrrgt/gt mutation
led to a female-specific effect on liver size. Histological analysis of fe-
male livers showed that Mtrrgt/gt hepatocytes were more densely packed
than controls (Fig. 1E-F) with greater nuclear density (nuclei per
0.1 mm2; p < .05) (Fig. 1I). It is possible that this was a result of
increased cell proliferation since the percentage of mitotic Ki67+ cells
was slightly higher in Mtrrgt/gt female livers (p = .059; Fig. 1G-H,J).
However, the expression of genes that regulate cell proliferation in the
liver (e.g., Myc [p = .0746] and C/ebpa [p = .0184]; Fig. 1K) was not
appreciably higher (1.3–1.6-fold change) in Mtrrgt/gt female livers re-
lative to controls. Besides being more densely arranged, Mtrrgt/gt he-
patocytes were eosinophilic (Fig. 1E-F), which might indicate an
aberrant accumulation of proteins [51] caused by cell stress [52] or
altered glycogen or lipid content (see Sections 3.3 and 3.4). We ob-
served that the cell stress gene Ddit3 was up-regulated by 2.2-fold in
Mtrrgt/gt female livers compared to controls (p = .0271; Fig. 1K).
Therefore, theMtrrgt/gt mutation might activate stress pathways in liver.
3.3. Analysis of glycogen storage in Mtrrgt/gt livers
Next, hepatic fuel storage was investigated in Mtrrgt/gt female livers.
First, periodic acid-Schiff (PAS) staining was performed on histological
sections of C57Bl/6J and Mtrrgt/gt female livers to assess glycogen sto-
rage (N = 3 livers per genotype). Fewer Mtrrgt/gt hepatocytes stained
positive for PAS (52.8 ± 11.2%, p < .0001) compared with controls
(76.0 ± 7.0%; Fig. 2A-C), and positive cells showed less intense PAS
stain in Mtrrgt/gt livers (Fig. 2A-B,D). However, when glycogen was
extracted from C57Bl/6J and Mtrrgt/gt female livers, direct biochemical
quantification of liver glycogen revealed that there was no difference in
hepatic glycogen concentration in Mtrrgt/gt female livers compared to
controls (Fig. 2E). These results indicated a discrepancy between the
histology and biochemical assay that might be explained by a degree of
inter-individual variability caused by ad libitum feeding or by the fact
that both the PAS stain and the phenol-sulphuric acid method are not
specific for glycogen [53]. However, the discrepancy observed is un-
likely to be due to major differences in glycogen content between liver
lobes [54].
To better understand the effects of the Mtrrgt mutation on hepatic
glycogen metabolism, expression of genes involved in glycogen synth-
esis (i.e., Gys2, Ugp2, Gbe1, Gyg, Gsk3a, and Gsk3b), and glycogen
breakdown (i.e., Agl and G6pc) were assessed via RT-qPCR in C57Bl/6J
and Mtrrgt/gt female livers. Glycogen synthesis regulator genes Ugp2 and
Gsk3a were down-regulated by ~2-fold in Mtrrgt/gt female livers com-
pared to C57Bl/6J controls (p < .002; Fig. 2F, G). All other genes
assessed displayed normal expression in Mtrrgt/gt female livers com-
pared to controls (Fig. 2F-H). UGP2 is an enzyme responsible for con-
verting glucose-1-phosphate to UDP-glucose, the precursor of glycogen.
In contrast, GSK3 negatively regulates glycogen synthesis [55,56] and
reduced expression of its gene in Mtrrgt/gt livers might indicate tran-
scriptional feedback associated with reduced hepatic glycogen. Down-
regulation of these genes in Mtrrgt/gt female livers substantiates the
histological data that showed reduced glycogen (Fig. 2B). Overall, these
data revealed dysregulation of hepatic glycogen synthesis in Mtrrgt/gt
females. However, to more fully understand the effect of the Mtrrgt al-
lele on hepatic glycogen metabolism, protein levels should be assessed.
3.4. Fatty acid metabolism but not lipid storage was altered in Mtrrgt/gt
livers
To further explore the effects of the Mtrrgt allele on hepatic fuel
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storage, lipid metabolism was investigated. Firstly, 3-hydoxyacyl-CoA
dehydrogenase (HOAD) activity was measured spectrophotometrically
in male and female liver to indicate whether β-oxidation of fatty acids
was altered by the Mtrrgt mutation. Regardless of sex, HOAD activity
was similar between C57Bl/6J control and Mtrrgt/gt livers (Fig. 3A).
Interestingly, HOAD activity in Mtrrgt/gt female livers was
139.9% ± 33.3% (mean ± sd) of the activity in Mtrrgt/gt males
(p= .008; Fig. 3A), yet this sexually dimorphic effect was not observed
in controls (Fig. 3A). When HOAD activity was normalized to citrate
synthase activity, a putative marker of mitochondrial content [57],
Mtrrgt/gt female livers displayed 22.5% less activity than C57Bl/6J fe-
male livers (p = .026; Fig. 3B-C). However, no differences were ap-
parent in males (Fig. 3BeC). Overall, these data suggested that the
Mtrrgt/gt mutation in mice might cause altered hepatic fatty acid meta-
bolism in a sexually dimorphic manner.
To determine whether reduced fatty acid metabolism in Mtrrgt/gt
female livers resulted in lipid accumulation, liver lipidomic analysis
was performed in C57Bl/6J and Mtrrgt/gt mice by LC-MS. Firstly, we
observed that the level of total carnitines (including free carnitine) and
the relative proportions of short- (C2–5), medium- (C6–12) and long-
chain (≥C13) acyl-carnitines of male and female Mtrrgt/gt livers were
comparable to the same-sex control group (Fig. 3D-E). While further
considering sex-specific differences, we observed that short-chain acyl-
carnitine levels were lower and long-chain acyl-carnitine levels were
higher in control female livers than male livers (p < .05; two-way
ANOVA, Sidak's multiple comparison; Fig. 3E). This was not apparent in
Mtrrgt/gt mice (Fig. 3D), which only displayed sexual dimorphism of
hepatic total carnitine, an effect that was absent in controls: Mtrrgt/gt
female livers had 43.1% less total carnitine (p = .045) than Mtrrgt/gt
male livers (two-way ANOVA, Tukey's multiple comparison; Fig. 3E).
Taken together with the HOAD activity data (Fig. 3C), these data sup-
ported the hypothesis that fatty acid handling was differently affected
in Mtrrgt/gt mice in a sexually dimorphic manner.
Next, open profiling of the hepatic lipidome was performed. Total
lipid content was unchanged in Mtrrgt/gt livers compared to same-sex
C57Bl/6J controls (Fig. 3F). Yet, there was a distinct sex-specific effect
of total lipid content regardless of genotype (Fig. 3F) that is consistent
with other studies [58,59]. For instance, C57Bl/6J female livers showed
22.0% more total lipid than C57Bl/6J males (p = .041) and similarly,
Mtrrgt/gt females livers had 28.3% more total lipid content than Mtrrgt/gt
males (p = .007; two-way ANOVA, Sidak's multiple comparison). Lipid
species were grouped by lipid class for further analysis. Similar to total
lipid content, levels of TAGs, DAGs, FFAs, cholesteryl-esters, ceramides,
sphingomyelins, and phospholipids were unchanged in male and female
Mtrrgt/gt livers when compared to same sex controls (Fig. 3G-H, Sup-
plementary fig. 1A). However, there was a sex-specific difference be-
tween TAGs levels regardless of genotype whereby female livers con-
sistently showed higher levels of specific medium-chain (48–54 carbon)
and long-chain (> 54 carbon) TAGs (p < .05; two-way ANOVA with a
Holm-Sidak correction for false discoveries, Sidak's multiple
Fig. 2. Mtrrgt/gt livers from female mice show altered glycogen
storage.
Representative histological sections showing two liver regions
of (A) C57Bl/6J and (B) Mtrrgt/gt female mice stained with
periodic acid-Schiff (PAS, dark pink; nuclei are counterstained
with hematoxylin [blue]). Black boxes indicate regions shown
in higher magnification to right. Scale bars: lowest magnifi-
cation, 2.5 mm; middle magnification, 500 μm; high magnifi-
cation, 50 μm. Graphs showing (C) the percentage of PAS+
liver cells and (D) the intensity of PAS staining (represented by
the percentage of image area with PAS stain) in histological
sections of C57Bl/6J livers and Mtrrgt/gt livers of female mice.
At least four liver regions were assessed per female. N = 3
females per genotype. Data is represented as mean ± sd.
Independent t-test, ***p < .005. (E) Hepatic glycogen con-
centration in female C57Bl/6J and Mtrrgt/gt mice. N = 8 livers
per group. Data is represented as mean ± sd. Independent t-
test. (FeH) Relative mRNA expression in C57Bl/6J control and
Mtrrgt/gt female livers was determined for (F) Gys2, Ugp2, Gbe1
and Gyg, (G) Gsk3a and Gsk3b and (H) Agl and G6pc as de-
termined by RT-qPCR analysis. N = 6 livers per group. Data is
presented as fold change relative to C57Bl/6J controls (nor-
malized to 1; mean ± sd). Independent t-tests, §p = .0599,
*p < .05, **p < .01, ***p < .001. Black circles, C57Bl/6J;
white circles, Mtrrgt/gt.
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comparison; Supplementary fig. 2). The medium-chain TAGs were
species rich in palmitic and oleic acid (Supplementary fig. 2A) and are
associated with de novo lipogenesis [60]. This data might account for
the increased total lipid content that was observed in the female livers.
In specific cases, such as in DAGs and phosphatidylinositol phos-
phates, there was a sex-specific effect in C57Bl/6 J livers (p < .05,
two-way ANOVA, Sidak's multiple comparison) that was absent in
Mtrrgt/gt livers (Fig. 3G, Supplementary fig. 1B-C). Conversely, there
were several lipid species whereby a sex-specific effect in liver was
generated by the Mtrrgt/gt mutation that was not apparent in controls.
More specifically, Mtrrgt/gt female livers contained more TAG, phos-
phatidylcholine and phosphatidic acid than male Mtrrgt/gt livers
(p < .05, two-way ANOVA, Sidak's multiple comparison; Fig. 3G-
H,Supplementary fig. 1B). Sexual dimorphism of the hepatic lipidome
suggested that male and female mice might be differently affected by
the Mtrrgt mutation. Overall, these data suggested that Mtrrgt/gt homo-
zygosity in female liver might alter fatty acid metabolism without
significantly affecting in lipid content.
3.5. Mtrrgt/gt livers display normal mitochondrial electron transfer system
function
Lastly, we aimed to assess whether the metabolic phenotype of
Mtrrgt/gt livers was related to changes in mitochondrial respiratory
function. First, the mRNA expression of a selection of nuclear-encoded
genes required for mitochondrial function (e.g., Ndufs4, Ndufs5, Ndufs6,
Isca1) was assessed. No significant differences in mRNA expression
between male and female C57Bl/6 J and Mtrrgt/gt livers were observed
(p > .114; Fig. 4A). Next, mitochondrial respiration rates were ana-
lysed in fresh C57Bl/6 J and Mtrrgt/gt liver homogenates by high-re-
solution respirometry (N = 4 males and N = 8 females per genotype).
No difference in flux was observed in livers of male or female Mtrrgt/gt
mice compared with controls, regardless of the state assayed (when
corrected to wet tissue mass; Fig. 4B-C). Similarly, when rates were
Fig. 3. Mtrrgt/gt female mouse livers show altered
fatty acid metabolism and not storage of lipids.
(A) 3-hydroxyacyl-CoA dehydrogenase (HOAD) en-
zyme activity, (B) citrate synthase (CS) activity, and
(C) HOAD activity relative to CS activity in male (m)
and female (f) C57Bl/6J and Mtrrgt/gt mouse liver.
N = 4–6 livers per group, mean ± sd. Two-way
ANOVA, Sidak's multiple comparison, *p < .05. (D)
Total carnitine species and (E) relative levels of
short-chain (C2-C5), medium-chain (C6-C12) and
long-chain (≥C13) acyl-carnitines to the total car-
nitine pool as measured by liquid chromatography-
mass spectrometry (LC-MS) in male (m) and female
(f) C57Bl/6J and Mtrrgt/gt mouse liver. (F) Total de-
tected lipid, (G) levels of triacylglycerol (TAG),
diacylglycerol (DAG) and free fatty acids (FFAs) and
(H) levels of phosphatidylethanolamine (PE) and
phosphatidylcholine (PC) measured through open
profiling lipidomics by LC-MS in male (m) and fe-
male (f) C57Bl/6J and Mtrrgt/gt mouse liver. See also
Supplementary fig. 1. Data in panels D-H are nor-
malized to an appropriate internal standard and
sample protein concentration. N = 8 livers per
group, mean ± sd. *p < .05, **p < .01,
***p < .001, Two-way ANOVA, Sidak's multiple
comparison. Squares, males; Circles, females; black,
C57Bl/6J; white, Mtrrgt/gt.
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corrected to GMSE (maximal ETS capacity) to provide a qualitative
indication of changes in mitochondrial function per mitochondrial unit,
oxygen flux rates were no different to controls (Fig. 4D-E). Altogether,
these data suggest that the Mtrrgt/gt mutation does not cause mi-
tochondrial dysfunction in the liver of adult mice.
4. Discussion
The Mtrrgt allele in mice causes defects in one‑carbon metabolism
including plasma hyperhomocysteimia, decreased plasma methionine,
increased tissue 5-methyl-THF, and altered cellular methylation
[21,35]. Similar to folate deficiency and MTRR mutations in humans
[30,32–34], metabolic derangement caused by Mtrrgt/gt homozygosity
in mice is associated with macrocytic anaemia [36] and a wide spec-
trum of developmental phenotypes (e.g., neural tube defects, cardiac
defects, fetal growth restriction) that display incomplete penetrance
[35]. Here, we investigated the effects of the Mtrrgt allele on liver me-
tabolism given that NAFLD has previously been associated with defects
in one‑carbon metabolism [2–8] and to better understand the larger
metabolic milieu in Mtrrgt/gt mice. We found adult Mtrrgt/gt female livers
were large and displayed eosinophilic hepatocytes, the appearance of
which was distinct from the lipid-filled vacuoles of hepatocytes asso-
ciated with steatosis caused by dietary folate deficiency and/or Mthfr
knockout mutation in mice [31,61]. Despite this, the Mtrrgt mutation
leads to changes in hepatic glycogen storage and β-oxidation of fatty
acids that occur independent of changes in electron transfer system
capacity.
The most striking phenotype of this study was the densely packed,
eosinophilic hepatocytes in Mtrrgt/gt female mice. The altered appear-
ance of Mtrrgt/gt hepatocytes might be explained by impaired glycogen
storage. Evidence for this hypothesis was reduced glycogen content in
Mtrrgt/gt female livers as determined by PAS stain in combination with a
down-regulation of genes involved in glycogen synthesis. Indeed, mice
fed a folate- and/or choline-deficient diet exhibit alterations in hepatic
DNA methylation of genomic regions that are associated with genes
related to carbohydrate metabolism [62]. In another context, folate
transporters (e.g., FOLR1) and metabolic enzymes (i.e., MTR and
MTHFR) are highly expressed in specialized placental cells involved in
glycogen storage and metabolism [63]. These observations support the
hypothesis that glycogen metabolism and folate metabolism might be
linked.
In conflict with the data above, glycogen concentration was un-
changed in Mtrrgt/gt livers compared to controls when biochemically
determined. While different liver lobes were assessed in the PAS stain
and the phenol-sulphuric acid method, glycogen content is typically
consistent between lobes [54] and is unlikely the cause of this dis-
crepancy. Given that glycogen is a multi-branched polysaccharide of
glucose, it is possible that the structure of glycogen is altered (e.g.,
branch lengths) in Mtrrgt/gt livers. As a result, PAS stain and phenol-
sulphuric acid method might differently recognize the glycogen pool
based on these hypothetical structural changes. Alternatively, PAS stain
also detects glycoproteins and proteoglycans in addition to glycogen
[64]. Therefore, changes in PAS staining intensity in Mtrrgt/gt female
livers might instead reflect major cellular changes, such as in con-
nective tissue and basal laminae. More sensitive assays, such as 13C
nuclear magnetic resonance [65] or amyloglucosidase digestion fol-
lowed by liquid chromatography/electrospray ionization–tandem mass
spectrometry quantification of the resultant free glucose [66] might
reveal more accurate changes in Mtrrgt/gt liver glycogen content. Ad-
ditionally, Mtrrgt/gt mice that are challenged by an obesogenic diet
might show more striking and consistent defects in glycogen synthesis
and/or metabolism relative to controls. This type of increased sensi-
tivity to dietary stress should be explored in the future.
Independent of glycogen storage, eosinophila of Mtrrgt/gt hepato-
cytes might be explained by aggregation of non-specific cytoplasmic
proteins [51]. Endoplasmic reticulum (ER) stress, a condition where
unfolded and misfolded proteins accumulate, is a feature of fibroblasts
of human patients with mutations in MTR [67]. These cells display
mislocalization of RNA binding proteins that prevent nucleo-cyto-
plasmic shuttling of RNA and splicing of mRNA [67], which likely has a
Fig. 4. Mitochondrial function is unchanged in livers of
Mtrrgt/gt adult mice.
(A) Relative mRNA expression of genes encoding for
nuclear-encoded mitochondrial genes in male (m) and
female (f) livers from C57Bl/6J control and Mtrrgt/gt
adult mice as determined by RT-qPCR analysis.
N = 3–5 females per genotype. Data is presented as
fold change relative to C57Bl/6J controls (normalized
to 1; mean ± sd). (B-E) Mitochondrial respiratory
function (JO2) in male and female livers from C57Bl/6J
and Mtrrgt/gt adult mice. GML, malate and glutamate
stimulate LEAK respiration through the N-pathway via
complex I; GMP, OXPHOS supported by glutamate and
malate through the N-pathway via complex I; GMSP,
OXPHOS supported by glutamate, malate and succinate
through the NS-pathway via complexes I and II; GMSE,
maximal ET capacity supported by malate, glutamate
and succinate through the NS-pathway via complexes I
and II in uncoupled mitochondria. Oxygen flux rates
were normalized to (B-C) wet tissue mass or to (D-E)
GMSE to indicate mitochondrial respiratory capacity
per mitochondrial unit. Squares, males; circles, females;
black, C57Bl/6J; white, Mtrrgt/gt.
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profound effect on post-transcriptional regulation and normal cell
function. Hyperhomocysteinemia, which is a prominent feature in
Mtrrgt/gt mice [21,35], associates with ER stress in other contexts
[68,69]. While we did not test specifically for protein aggregation in
eosinophilic Mtrrgt/gt female livers, an up-regulation of the Ddit3 gene
implicates ER stress. Whether this is a primary or secondary effect of the
Mtrrgt allele is unclear. Further experimentation is required to more
fully understand how the Mtrrgt/gt mutation causes eosinophilic hepa-
tocytes and its relationship to cell stress.
Given that homocysteine aids TAG accumulation [70,71], one
reason why perturbation of one‑carbon metabolism alters lipid content
and hepatosteatosis is the presence of hyperhomocysteinemia. Others
have shown via reduced representation bisulfite sequencing analysis
that Mtrrgt/gt livers have patterns of differential methylation of DNA
compared to wildtype littermates [72]. Some of the affected genomic
regions included genes associated with lipid metabolism [72], though
the functional relevance of this differential methylation is yet-to-be
determined. Despite increased plasma total homocysteine and altered
liver DNA methylation in Mtrrgt/gt mice, the only detectable effect of
Mtrrgt/gt mutation on lipid metabolism was reduced β-oxidation of fatty
acids in female livers. While hepatic fatty acid oxidation was also im-
paired in rats fed a methyl-donor deficient diet, these rats also dis-
played carnitine deficit and liver steatosis [73], features that were ab-
sent in Mtrrgt/gt livers. In fact, lipid content and metabolism was within
the normal range in Mtrrgt/gt female and male livers.
NAFLD and glycogen storage disease are often accompanied by al-
terations in mitochondrial OXPHOS and/or ETS function [37–40].
Furthermore, folate metabolism is essential for the methylation of mi-
tochondrial tRNA required for successful mRNA translation in the mi-
tochondria [74] to ensure respiratory complexes for OXPHOS are
functioning [75]. No difference in JO2 in any of the states assayed was
observed in Mtrrgt/gt liver. This result is consistent with only subtle
changes in lipid and glycogen metabolism and demonstrates that he-
patic mitochondrial function was unaltered by the Mtrrgt/gt mutation.
It is unclear why folate deficiency and not the Mtrrgt/gt mutation
cause steatosis of the liver. The Mtrrgt allele in mice is robust enough to
cause many of the same phenotypes as humans withMTRRmutations or
folate deficiency (e.g., hyperhomocysteinemia, anaemia, neural tube
defects, fetal growth restriction) [21,30,32–36]. The macrocytic
anaemia phenotype in Mtrrgt/gt female mice is late-onset at 22 weeks of
age [36]. It is possible that liver disease also appears later in life in
Mtrrgt/gt mice and was not apparent in our study since 9–16 week-old
mice were assessed. Alternatively, the Mtrrgt allele is a knockdown ra-
ther than knockout mutation, with 24% of wildtype Mtrr transcripts
remaining in Mtrrgt/gt female livers. This level of expression might be
sufficient for lipid metabolism to proceed and a conditional knockout of
Mtrr expression specific to the liver might be required to induce more
severe effects on lipid metabolism and steatosis. More severe metabolic
liver phenotypes may also be uncovered through exposing the Mtrrgt/gt
mouse to a high fat diet (e.g. [31]), a NASH-inducing diet containing
trans-fats, (e.g [76]), or a folate-deficient diet (e.g. [77]).
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